5/9
04:24 pm
lmat
Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance [Yahoo! Finance]
Low
Report
Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance [Yahoo! Finance]
5/5
09:28 am
lmat
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]
Medium
Report
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]
5/4
09:33 am
lmat
LeMaitre Vascular First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
LeMaitre Vascular First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
5/3
11:32 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
5/3
05:11 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its price target raised by analysts at JMP Securities from $72.00 to $77.00. They now have a "market outperform" rating on the stock.
Medium
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its price target raised by analysts at JMP Securities from $72.00 to $77.00. They now have a "market outperform" rating on the stock.
5/3
05:05 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $69.00 to $79.00. They now have an "outperform" rating on the stock.
Medium
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $69.00 to $79.00. They now have an "outperform" rating on the stock.
5/3
11:42 am
lmat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/2
07:52 pm
lmat
LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates [Yahoo! Finance]
Medium
Report
LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates [Yahoo! Finance]
5/2
04:05 pm
lmat
LeMaitre Q1 2024 Financial Results
Medium
Report
LeMaitre Q1 2024 Financial Results
4/26
07:03 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $75.00 price target on the stock, up previously from $59.00.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $75.00 price target on the stock, up previously from $59.00.
4/19
11:42 am
lmat
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
Low
Report
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
4/19
09:44 am
lmat
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? [Yahoo! Finance]
Low
Report
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? [Yahoo! Finance]
4/16
02:07 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
4/8
11:03 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
4/5
09:20 am
lmat
When Should You Buy LeMaitre Vascular, Inc. (NASDAQ:LMAT)? [Yahoo! Finance]
Low
Report
When Should You Buy LeMaitre Vascular, Inc. (NASDAQ:LMAT)? [Yahoo! Finance]
3/31
02:08 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/26
04:52 pm
lmat
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference
Low
Report
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference
3/23
02:08 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
3/22
07:44 am
lmat
Investing in LeMaitre Vascular (NASDAQ:LMAT) five years ago would have delivered you a 137% gain [Yahoo! Finance]
Low
Report
Investing in LeMaitre Vascular (NASDAQ:LMAT) five years ago would have delivered you a 137% gain [Yahoo! Finance]
3/15
11:02 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/8
05:52 am
lmat
Be Sure To Check Out LeMaitre Vascular, Inc. (NASDAQ:LMAT) Before It Goes Ex-Dividend [Yahoo! Finance]
Low
Report
Be Sure To Check Out LeMaitre Vascular, Inc. (NASDAQ:LMAT) Before It Goes Ex-Dividend [Yahoo! Finance]
3/7
04:23 pm
lmat
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024 [Yahoo! Finance]
Low
Report
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024 [Yahoo! Finance]
3/5
01:18 pm
lmat
LeMaitre Vascular (LMAT) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
Low
Report
LeMaitre Vascular (LMAT) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
3/5
11:11 am
lmat
Best Momentum Stocks to Buy for March 5th [Yahoo! Finance]
Low
Report
Best Momentum Stocks to Buy for March 5th [Yahoo! Finance]
3/4
11:05 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.